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Maintenanceof lymphoid homeostasis in a number of
immunological and inflammatory contexts is served
by a variety of regulatory T (Treg) cell subtypes and
depends on interaction of the transcription factor
FoxP3 with specific transcriptional cofactors. We
report that a commonly used insertional mutant of
FoxP3 (GFP-Foxp3) modified its molecular interac-
tions, blocking HIF-1a but increasing IRF4 interac-
tions. The transcriptional profile of these Treg cells
was subtly altered, with an overrepresentation of
IRF4-dependent transcripts. In keeping with IRF4-
dependent function of Treg cells to preferentially
suppress T cell help to B cells and Th2 and Th17
cell-type differentiation, GFP-FoxP3 mice showed
a divergent susceptibility to autoimmune disease:
protection against antibody-mediated arthritis in the
K/BxN model, but greater susceptibility to diabetes
on the NOD background. Thus, specific subfunctions
of Treg cells and the immune diseases they regulate
can be influenced by FoxP3’s molecular interactions,
which result in divergent immunoregulation.
INTRODUCTION
The transcription factor FoxP3 plays a central role in specifying
the differentiation and function of regulatory T (Treg) cells.
FoxP3+ Treg cells help maintain lymphoid homeostasis in a
number of immunological contexts: tolerance to self versus
autoimmune deviation, responses to pathogens or allergens,
and interactions with commensal microbes (Campbell and
Koch, 2011; Barnes and Powrie, 2009; Feuerer et al., 2009b).
The importance of FoxP3+ Treg cells is highlighted by the devas-
tating multiorgan inflammation of FoxP3-deficient scurfymice or
human IPEX patients (Ziegler, 2006). In addition, FoxP3+ Treg
cells partake in extraimmune regulatory activities, for instance
by dampening inflammation and metabolic activity in visceral
adipose tissue (Feuerer et al., 2009a).
Several pathways and molecular mediators of Treg cell
function have been described—some involving cell-cell interac-
tions, others soluble cytokines or small-molecule mediators
(Vignali et al., 2008; Shevach, 2009). Correspondingly, a number
of Treg cell subphenotypes exist, with differential effector func-tions and tissue localization (Feuerer et al., 2009a; Feuerer
et al., 2010; Campbell and Koch, 2011). Although Treg cells
generally share a transcriptional program that distinguishes
them from conventional CD4+ (Tconv) cells, this program is
modified and tuned in relation to Treg cell function. For instance,
Treg cells in the adipose tissue express a set of transcripts
reflective of homing and adaptation to the adipose environment
and to the functions they exert there (Feuerer et al., 2009a and
data not shown). These programs appear to be determined in
Treg cells by the same transcription factors that are central to
the differentiated functions of the Tconv cells they regulate. For
instance, IRF4 is required for the differentiation of B cells and
of the T helper 2 (Th2)-type cells that help them, and the absence
of IRF4 in Treg cells impairs their ability to control Th2 cell
responses and antibody production (Zheng et al., 2009). Simi-
larly, Treg cells expressing T-bet or STAT3 transcription factors
optimally suppress inflammatory Th1 and Th17 cell responses,
respectively (Koch et al., 2009; Chaudhry et al., 2009).
Underscoring this specialization of Treg cell functionalities,
FoxP3 engages in a number of interactions with other transcrip-
tion factors (Xiao et al., 2010). Through its leucine zipper region,
FoxP3 can dimerize with itself or with other forkhead domain
proteins (Lopes et al., 2006; Li et al., 2007b) and can homodimer-
ize through the formation of a peculiar domain-swapped dimer of
the DNA-binding forkhead domain (Bandukwala et al., 2011).
FoxP3 interacts with the transcription factors Runx1, NF-AT,
Eos (encoded by Ikzf4), IRF4, RORgt, RORa, and phosphorylated
STAT3 (Ono et al., 2007; Wu et al., 2006; Pan et al., 2009; Zheng
et al., 2009; Zhou et al., 2008; Chaudhry et al., 2009). Several of
these interactions have been linked to a particular facet of the
Tregcell transcriptional profile; for instance, IRF4orSTAT3subtly
affect, alone or in combination with FoxP3, discrete segments of
the Treg cell signature (Zheng et al., 2009; Chaudhry et al., 2009).
This diversity of Treg cell subphenotypes and interacting fac-
ets of FoxP3 suggests that shifts in these interactions, occurring
physiologically or experimentally, should modulate the range of
Treg effector abilities. Here, we report such a situation, where
a modification of FoxP3 results in diametrically opposite effects
on the severity of different autoimmune diseases.
RESULTS
Divergent Autoimmune Phenotypes in Mice Carrying
the Foxp3fgfp Knockin
Our initial observations were made serendipitously in the course
of analyzing the role of FoxP3+ Treg cells in the K/BxN model ofImmunity 36, 731–741, May 25, 2012 ª2012 Elsevier Inc. 731
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Figure 1. Foxp3fgfp Mice Exhibit Contrasting Phenotypes in Different Autoimmune Models
(A) Schematic representation of FoxP3, GFP-FoxP3, and FoxP3-I-GFP. Protein convertase cleavage sites (RXXR), proline-rich regions (Pxxp1 and Pxxp2), and
leucine zipper (Leu-zip) and forkhead (FKH) domains are represented.
(B) Arthritis clinical score and ankle measurements of 8-week-old K/BxN.Foxp3fgfp males, K/BxN.Foxp3fgfp/wt heterozygote females, and WT littermate
control mice.
(C) Anti-GPI IgG reactivity in sera of 8-week-old K/BxN.Foxp3fgfp males, K/BxN.Foxp3fgfp/wt females, and WT littermate control mice (mean ± SD, n = 6–8).
(D) Arthritis clinical score, ankle thickness, and anti-GPI antibodies in 8-week-old male and female K/BxN.Foxp3igfp and WT controls (mean ± SD, n = 6–8).
(E) Diabetes incidence curves of NOD.Foxp3fgfp males NOD.Foxp3fgfp/wt, females and littermate controls (10 mice/group). Two different cohorts of
NOD.Foxp3fgfp/wt heterozygous females were followed, in two different animal facilities.
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Different Treg Cell Functions in Autoimmunityinflammatory arthritis. These mice carry the KRN transgene,
which encodes a T cell receptor (TCR) reactive against a peptide
from the ubiquitous enzyme, glucose-6-phosphate isomerase
(GPI), presented by the MHC class II molecule Ag7 (Kouskoff
et al., 1996). When the KRN transgene is crossed into an Ag7-
positive genetic background, autoreactive T cells promote the
massive production of anti-GPI IgG, which rapidly and spontane-
ously induce arthritis. They can also provoke arthritis after trans-
fer into normal recipients (Korganow et al., 1999). To help identify
Treg cells in arthritic mice, we introduced into K/BxN mice the
Foxp3gfp (Foxp3tm2Ayr) reporter knockin from Fontenot et al.
(2005), in which the eGFP coding region is inserted in-frame732 Immunity 36, 731–741, May 25, 2012 ª2012 Elsevier Inc.into the coding region of the Foxp3 locus on the X chromosome,
yielding a functional chimeric fusion protein with GFP inserted
between amino acids 5 and 6 of FoxP3 (Figure 1A; the locus
encoding this fusion protein will be referred to as Foxp3fgfp). It
is distinguished from the bicistronic ires-driven reporter
Foxp3igfp of Bettelli et al. (2006), in which GFP is not fused with
FoxP3 but is concomitantly expressed from a bicistronic
mRNA, leaving FoxP3 intact, and which was used as a control
throughout this study.
We noticed that the presence of the Foxp3fgfp reporter modi-
fied considerably the course of K/BxN arthritis. Males developed
no or very mild arthritis, as judged by both ankle thickening and
AE F
B C D
Figure 2. Foxp3fgfp Disease Phenotype Does Not Correlate with an Alteration in Treg Cell Frequency
(A and B) Percentage of FoxP3-positive cells within CD4+ T cells.
(A) Spleens and draining lymph nodes (popliteal) of 8-week-old WT and K/BxN.Foxp3fgfp males (each point is an individual mouse).
(B) Spleen and pancreas of 9-week-old NOD.Foxp3fgfp males and controls.
(C) Proportion of FoxP3+ Treg cells among LN and visceral adipose tissue of 40-week-old B6 males.
(D) Representative dot plots showing the percent FoxP3+ Helios Treg cells in colon lamina propria and spleen of 6-week-old B6.Foxp3fgfp and B6.Foxp3igfp
males.
(E) Splenocytes from K/BxN.Foxp3fgfp/wt heterozygote females were stained with CD3, CD4, and FoxP3 antibodies. Gates and values represent the fraction of
GFP-positive and -negative cells among FoxP3+ population. A summary of data in adjacent plot shows a fraction of GFP+ cells among FoxP3+ cells in the thymus,
spleen, and draining lymph nodes of K/BxN.Foxp3fgfp/wt females; the dashed line denotes the 50/50 ratio expected from random X-chromosome inactivation.
(F) Linear regression analysis of serum anti-GPI levels versus the fraction of GFP+ FoxP3+ Treg cells in K/BxN.Foxp3fgfp/wt heterozygote females.
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Different Treg Cell Functions in Autoimmunityclinical index (Figure 1B). Protection in females was less
extreme, with a delay in disease onset (Figure S1A available
online) and variable severity. K/BxN.Foxp3fgfp males had low to
undetectable amounts of arthritogenic anti-GPI, in contrast to
serum of K/BxN littermates (Figure 1C). K/BxN.Foxp3fgfp hetero-
zygote females also showed a significant reduction in anti-GPI,
albeit less dramatic; these titers correlated well with arthritis
severity (Figure S1A). These data imply that protection from
arthritis in K/BxN.Foxp3fgfp mice stemmed from a block in auto-
antibody formation, suggesting an active suppression of the
immunologic phase of this model. This idea was further substan-
tiated by the fact that B6.Foxp3fgfp animals were sensitive to
arthritis induced by transfer of arthritogenic K/BxN serum (Fig-
ure S1B). To address the possibility that protection from arthritis
was simply due to GFP expression, we used the FoxP3-ires-GFP
reporter line (Bettelli et al., 2006). K/BxN.Foxp3igfp mice devel-
oped anti-GPI and arthritis as usual (Figure 1D), ruling out this
interpretation.
Given this protection from arthritis, we next examined whether
mice expressing GFP-FoxP3 would also be protected from other
autoimmune diseases. Thus, the Foxp3fgfp knockin was back-
crossed for 12 generations to the NOD/Lt strain, the prototypical
model of autoimmune type-1 diabetes (T1D), and evaluated
through the course of diabetes. Surprisingly, the opposite result
was obtained: whereas male NOD mice are usually resistant to
diabetes, NOD.Foxp3fgfp males showed a very high incidence
of diabetes (Figure 1E). Similarly, NOD.Foxp3fgfp heterozygote
females exhibited an acceleration of diabetes, in two indepen-dent cohorts; some animals became diabetic before 10 weeks
of age, which is never seen in our NOD colony.
Foxp3fgfp Treg Cells Impact Disease Independent of
Frequency
Because FoxP3 is exclusively expressed in Treg cells and condi-
tions their differentiation and maintenance, we first examined
whether differences in Treg cells between mice expressing
GFP-FoxP3 might account for the contrasting phenotypes in
the two autoimmune models. Flow cytometric analyses first
focused on male mice, in which the Foxp3fgfp phenotypes
were most obvious, and on the spleen, where most of the
anti-GPI of K/BxN mice are produced. No increase in the
fraction of FoxP3+ among CD4+ splenocytes was observed in
K/BxN.Foxp3fgfp relative to K/BxN male mice (Figure 2A), as
might have been expected from the suppression of disease.
Instead, there was a decrease in the frequency of Treg cells, in
mice expressing GFP-FoxP3, most significantly in the lymph no-
des. A similar trend to decreased Treg cell frequency was
observed in spleens of NOD.Foxp3fgfp mice; however, this
observation did not extend to the pancreas (Figure 2B). Thus,
the difference in disease severity imparted by Foxp3fgfp in these
two models does not correlate with altered proportions of Treg
cells in the key organs.
In view of the impact of the chimeric GFP-FoxP3 on distinct
Treg cell populations, we investigated whether other Treg cell
pools might be similarly affected. We have recently described
a particular population of FoxP3+CD4+ T cells that resides inImmunity 36, 731–741, May 25, 2012 ª2012 Elsevier Inc. 733
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Figure 3. Decrease in Th17 Cells in K.BxN.Foxp3fgfp Mice Is Independent of Inherent Th17 Cell Differentiation Defect
(A) IL-17a-producing cells in spleen and small intestine lamina propria from 4- to 5-week old K/BxN and K/BxN.Foxp3fgfpmale mice. Gates and values represent
fraction of IL-17a-positive cells in CD4 population. Data are summarized in adjacent graph. Data are representative of three independent experiments.
(B) In vitro Th17 and Treg cell differentiation of congenically marked naive cells from WT (CD45.1) and Foxp3fgfp (CD45.2) B6 mice. Data is representative of two
independent experiments.
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Different Treg Cell Functions in Autoimmunitythe abdominal adipose tissue, has a distinctive TCR repertoire
and transcriptional profile, and impacts metabolic parameters
(Feuerer et al., 2009a). In aged males, in which this population
is most abundant, mice expressing GFP-FoxP3 showed a
marked reduction in numbers of fat Treg cells (Figure 2C).
Another recently described Treg cell population is found in the
colonic mucosa, induced by exposure to components of the gut
microbiome, in a particular Clostridia species (Atarashi et al.,
2011). This population differs from Treg cells in secondary
lymphoid organs by not expressing the transcription factor
Helios (encoded by Ikzf2), which has been suggested to identify
thymus-derived Treg cells (Thornton et al., 2010), although the
correlation is probably not absolute (data not shown). We evalu-
ated the representation and Helios expression of FoxP3+ Treg
cells in the colonic lamina propria (LP) of B6.Foxp3fgfp males.
Significantly, more Foxp3fgfp Treg cells lacked Helios than did
Treg cells from B6.Foxp3igfp or unmodified B6 mice, but no
difference was observed in splenic Treg cells (Figure 2D). These
results suggest that there may be an increased conversion to
a Treg cell phenotype in the colon of Foxp3fgfp mice in response
to local microbiota.
In heterozygous female mice, we noted a significant imbal-
ance in the fraction of FoxP3+ cells expressing the Foxp3fgfp
knockin allele. Random X inactivation should result in equivalent
representation of Foxp3 alleles from both chromosomes, unless
one conferred a particular advantage or disadvantage to the
cells expressing it. This ratio of GFP+/GFP among FoxP3+ cells
was skewed in splenic Treg cells of most K/BxN.Foxp3fgfp
females (Figure 2E), variably in individual mice, and ranging
down to 1:4 (Figure 2E). This disproportion was evident early in
differentiation of the Treg cell lineage in the thymus, probably re-
flecting a lower efficacy of selection. This thymic imbalance was
most evident in K/BxN.Foxp3fgfp females, perhaps because of
their self-reactive TCR, given that it was more discrete in non-
transgenic B6 and NOD females (data not shown). We used
this variability to our advantage by assessing whether there
was a relationship between percent Foxp3fgfp Treg cells and
anti-GPI titers. Indeed, anti-GPI titers were inversely correlated734 Immunity 36, 731–741, May 25, 2012 ª2012 Elsevier Inc.with the proportion of GFP+ cells among Treg cells in K/BxN
females (Figure 2F).
Thus, the GFP-FoxP3 protein seems to alter in opposite ways
the selection or stability of Treg cells that express it. But, whether
comparing males to females, or females with different allelic
inactivation, there is a strong correlation between the effect on
autoimmune disease and the representation of Treg cells ex-
pressing the GFP-FoxP3 protein, indicating that Foxp3fgfp Treg
cells are directly involved in altering the course of autoimmune
diseases described above.
Th17 Cells in K/BxN.Foxp3fgfp Mice
Th17 cells play a central role in K/BxN arthritis, most directly by
modulating the amounts of arthritogenic anti-GPI (Jacobs et al.,
2009; Wu et al., 2010). Given the low anti-GPI in K/BxN.Foxp3fgfp
mice, we assessed the Th17 cell population in these mice.
K/BxN.Foxp3fgfp male mice showed a significant decrease in
the frequency of Th17 cells in the small intestine lamina propria
(SI-LP) relative to control K/BxN.Foxp3igfp mice (Figure 3A).
Preliminary data from NOD.Foxp3fgfp mice follow a similar trend.
This difference could be due to an intrinsic defect in Th17 cell
differentiation (conceivable given the notion that interactions
between FoxP3 and RORgt control the differential toward Th17
or iTreg cells [Zhou et al., 2008]) or to stronger suppression of
IL17 production by Treg cells expressing the GFP-FoxP3
protein. We tested the former by using an in vitro Th17 cell differ-
entiation system. To control for interwell variation or indirect
effects, we mixed congenically marked naive T cells from
B6.CD45.1 and B6.Foxp3fgfp (CD45.2) mice and cultured them
together under Th17 cell skewing conditions (Figure 3B). In
cultures lacking IL-6, FoxP3+ cells were similarly induced in
Foxp3fgfp or Foxp3wt cells (Figure 3B, left panels). IL-17-
producing cells were induced by IL-6 at similar frequencies in
Foxp3fgfp or Foxp3wt cells, at either concentration of TGF-b, indi-
cating that there is no intrinsic defect of Th17 cell differentiation.
We also searched for a Th cell bias in gene expression profiles of
unstimulated Tconv cells from NOD or B6.Foxp3fgfp. No bias in
typical Th1, Th2, or Th17 cell transcriptional signatures were
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Figure 4. Elevated FoxP3 Expression in Foxp3fgfp Treg Cells
(A) Anti-FoxP3 staining profiles of CD3+CD4+ cells from different organs of K/BxN.Foxp3fgfp male or WT littermates (shaded area is profile from isotype control).
Data are representative of three independent experiments.
(B) FoxP3 mean fluorescence intensity (MFI) of splenic Treg cells on three different backgrounds. Each dot represents an individual mouse, and values are
normalized to the mean FoxP3 MFI of WT mice in each experiment.
(C) FoxP3 MFI for LN and visceral fat from 40-week-old B6.Foxp3fgfp mice.
(D) Foxp3 mRNA levels in CD4+GFP+ splenic Treg cells from Foxp3fgfp or WT male mice on two different backgrounds.
Immunity
Different Treg Cell Functions in Autoimmunityobserved (Figure S2), indicating that the defective IL-17 induc-
tion is only revealed in challenged conditions, such as those of
the K/BxN LP.
Altered Characteristics of Foxp3fgfp Treg Cells
The impact of GFP-FoxP3 on differentiation of several Treg cell
compartments and the correlation between GFP-FoxP3 expres-
sion and autoimmune disease suggested that the chimeric
protein might modify particular regulatory aspects or phenotypic
characteristics in Treg cells, and thereby impact arthritis or dia-
betes progression. To elucidate these mechanistic underpin-
nings, we analyzed several aspects of Treg cell phenotype and
function.
The FoxP3 mean fluorescence intensity (MFI) was increased
by 2-fold in Foxp3fgfp Treg cells in K/BxN males (Figure 4A),
evident from early Treg cell differentiation in the thymus. This
increase was also present on the B6 and NOD genetic back-
grounds (Figure 4B) and was equivalent in males and females.
The FoxP3 chimeric protein was also overrepresented, to
a less marked degree, in Treg cells from visceral fat and in the
pancreatic infiltrate of NOD mice (Figure 4C). This overexpres-
sion of FoxP3 was not reflected at the mRNA level (Figure 4D),
suggesting that the increase in FoxP3 reflected an effect on
the stability of the protein, perhaps through different suscepti-
bility to posttranslational modifications. At any rate, it is clear
that the addition of GFP does not destabilize FoxP3.
We then tested the functional activity of Foxp3fgfp Treg cells. In
the conventional in vitro Treg cell suppression assay, Foxp3fgfp
Treg cells showed a small increase in suppressor activity (Fig-
ure 5A), consistent with the results of Fontenot et al. (2005),
who also observed a small shift. This difference was observed
only when responder T cells were activated in the presence of
irradiated antigen-presenting cells (APCs), given that direct
activation of responder T cells, with a plate-bound anti-CD3
antibodies or anti-CD3 and anti-CD28 conjugated beads, did
not reveal this enhanced suppression (data not shown). The
limited difference in suppressive activity in vitro was clearly not
sufficient to account for the divergent effects on the course of
arthritis and diabetes, which could be explained by modifica-
tions in the balance of different effector functions of Treg cells.
To test this hypothesis, we cultured naive T cells under Th1,Th2, and Th17 cell-skewing conditions in the absence or pres-
ence of GFP-FoxP3 or IGFP-FoxP3 Treg cells. Transcripts of
the key indicator cytokines (Ifng, Il17a, and Il4) were quantitated
by RT-PCR so that specific Th cell-subset differentiation could
be determined. Expression of Ifng and Il4 were equally sup-
pressed by both GFP- and IGFP-FoxP3 Treg cells (Figure 5B),
but GFP-FoxP3 Treg cells were significantly more efficient at
blocking Th17 cell differentiation than their IGFP counterparts.
This greater efficiency may explain the decrease in SI-LP Th17
cells in K/BxN.Foxp3fgfp animals.
To further shed light on the differences between Foxp3fgfp and
WT Treg cells, we compared their transcriptional profiles on
gene expression microarrays. To properly compare Treg cell
populations, we sorted to high purity CD3+CD4+GFP+ (Treg)
and CD3+CD4+GFP (Tconv) cells from both Foxp3fgfp and
Foxp3igfp mice. We performed this comparison on both the B6
and NOD inbred backgrounds to generate independent data
sets and to avoid potential confounders from the strong inflam-
matory alterations in the K/BxN context. The expression plots
of Figure 6A, which compare Treg and Tconv cells and highlight
the canonical Treg cell signature (Hill et al., 2007), give a broad
perspective and show that GFP+ cells in B6.Foxp3fgfp mice are
indeed Treg cells, with the usual complement of over- and under-
expressed transcripts, consistent with the results of Fontenot
et al. (2005). Next, we sought finer differences between Foxp3fgfp
and Foxp3igfp Treg cells by direct comparison of Treg cell
profiles in both strains (Figure 6B). Treg cells from Foxp3fgfp
and Foxp3igfp were very similar, with only 74–151 transcripts
overexpressed in Foxp3fgfp Treg cells at an arbitrary threshold
of 1.5-fold (for comparison, the experimental noise estimated
by Monte Carlo randomization and sampling randomization
was 60 and 197 hits, respectively, at the same threshold).
Many of the transcription factors that were key in establishing
the Treg cell signature were equivalently expressed (green dots
in Figure 6B). In contrast, 39 of these differential transcripts
showed a comparable deviation when the Foxp3fgfp versus
Foxp3igfp comparison was made on both the B6 and NOD back-
grounds, providing cross-confirmation from independent data
sets (only 6.54 overlaps on average in randomized data sets,
p < 104). Further substantiating the significance of these
discrete differences, Foxp3fgfp-differential transcripts were notImmunity 36, 731–741, May 25, 2012 ª2012 Elsevier Inc. 735
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Figure 5. Enhanced Treg Cell Function Observed in Foxp3fgfp Treg Cells
(A) In vitro suppressive ability of CD4+CD25+ Treg cells from B6.Foxp3fgfp or WT littermates, titrated at different ratios in cocultures with CD4+ Tconv responder
cells and APCs. Data represent mean proliferation ± SD of three independent experiments.
(B) Th17 cell differentiation suppressed by GFP-FoxP3 (FGFP) and FoxP3-ires-GFP (IGFP) Treg cells. Ifng, Il17a, and Il4mRNA expression levels were assessed
by quantitative RT-PCR.
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Different Treg Cell Functions in Autoimmunitya random assortment of transcripts but included a number of
genes of established relevance to Treg cells (Figure 6C): effector
molecules (Il10, Ctla4, and Fgl2), cell-surface receptors (Klrg1
and Icos), migration factors (Itgae, Ccr2, Ccr5, and Cxcr3), and
transcription factors (Prdm1, Maf, and Ahr). This signature
included several transcripts typically overexpressed in the
CD103+KLRG1+ Treg cell subset (Feuerer et al., 2010). These
differences in KLRG1, CD103, and CTLA4 expression were
confirmed by flow cytometry in Foxp3fgfp heterozygote K/BxN
and NOD females, which allow a direct comparison in the
same mouse of Treg cells expressing WT versus chimeric
FoxP3 (Figure 6D).
We then examined whether this differential representation
overlapped with any of the subsignatures that characterize
Treg cell subphenotypes, in particular those linked to STAT3
and IRF4, which are associated with the ability of Treg cells to
control Th17 cell- and Th2 cell-related functions. We hypothe-
sized that the over-riding suppression of anti-GPI responses in
the arthritis model, or to the higher efficacy at suppressing
IL17 responses, might be due to one of these sub-signatures.
Using the IRF4- or STAT3-dependent gene-sets previously
defined in mutant Treg cells (Zheng et al., 2009; Chaudhry
et al., 2009), we observed no bias for STAT3-dependent tran-
scripts (data not shown) but there was a significant overrepre-
sentation of IRF4-dependent transcripts in Foxp3fgfp Treg cells,
on both B6 and NOD backgrounds (Figure 6E). Thus, Treg cells
expressing the chimeric FoxP3 do not show a skewing of the
entire Treg cell signature, but only a very focused bias, which
overlaps with the imprint of IRF4, previously associated with
the control of T helper activity and antibody production.
Altered Protein-Protein Interactions between GFP-
FoxP3 and Transcriptional Cofactors
This limited and focused effect of GFP-FoxP3 on the Treg cell
signature suggested that the insertion of eGFP into FoxP3 might
affect its physical interaction with some of its functional cofac-
tors. We thus performed coimmunoprecipitation experiments
with Treg cell extracts from Foxp3fgfp and matched control
littermates or Foxp3igfp mice. FoxP3 was immunoprecipitated
from nuclear lysates, and associated factors were detected by736 Immunity 36, 731–741, May 25, 2012 ª2012 Elsevier Inc.SDS-PAGE immunoblotting. We first tested the association of
FoxP3 with FoxP1, a heterodimer formation known to occur via
the leucine-zipper region (Lopes et al., 2006; Li et al., 2007b)
and thus presumably away from the GFP insertion site. Coimmu-
noprecipitation of FoxP1 was equivalent with both FoxP3 and
GFP-FoxP3 (Figure 7A), indicating that the overall structure of
GFP-FoxP3 was not grossly perturbed. In contrast, the interac-
tion with the transcription factor HIF1-a, recently suggested to
antagonize Treg cell differentiation by promoting FoxP3 protea-
somal degradation (Shi et al., 2011; Dang et al., 2011), was
almost completely abrogated in GFP-FoxP3 relative to WT
FoxP3 (Figure 7B); this loss of interaction may plausibly account
for the increased amount of FoxP3 protein observed (Figure 4A).
The interaction of FoxP3 with IRF4 was tested by coimmunopre-
cipitation with anti-IRF4, revealing a higher amount of FoxP3-
IRF4 complexes in Foxp3fgfp Treg cells relative to control cells
(Figure 7C), consistent with the overrepresentation of IRF4-
dependent gene transcripts. In the course of these experiments,
we also observed that IRF4 protein expression itself is higher in
Foxp3fgfp Treg cells (Figure 7D), which may contribute to the
elevated IRF4-GFP-FoxP3 interaction.
DISCUSSION
The observations reported here imply that perturbations in
Treg cell phenotype and functional characteristics can affect
autoimmune diseases in a diametrically opposite manner. These
can be traced to a discrete genomic signature, identifying
candidates for this biased function, and to perturbations in the
interaction between FoxP3 and transcriptional cofactors. These
results indicate that specific modifications of FoxP3 and of its
interactions may be at play during the unfolding of autoimmune
diseases and could serve as a basis for therapeutically modu-
lating Treg cell function in a qualitative manner.
From a practical standpoint, these results need to be taken
into consideration in the interpretation of some experiments
performed with the Foxp3fgfp line in recent years. Foxp3fgfp
reporter mice have been used by a large number of investigators
to track Treg cells. In some cases we would anticipate the
discrete phenotypic and transcriptional perturbations reported
AC
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Figure 6. Biased Gene Expression in Foxp3fgfp Treg Cells
Gene expression profiles were generated by microarray of Treg and Tconv cells from B6.Foxp3fgfpmales, with parallel profiling from B6.Foxp3igfp as a reference.
(A) Comparison of expression values in Treg versus Tconv splenocytes from Foxp3fgfp and Foxp3igfp B6 males. The canonical Treg cell signature is highlighted in
red (Treg cell-upregulated transcripts) and blue (Treg cell-downregulated transcripts).
(B) Comparison of expression values in Foxp3fgfp and control Foxp3igfp Treg splenocytes, on B6 and NOD backgrounds. Genes concordantly overexpressed in
Foxp3fgfp relative to Foxp3igfp in both backgrounds are highlighted in red. Transcription factor genes are represented in green.
(C) Heatmap representation of transcripts over-represented in Foxp3fgfp on both backgrounds.
(D) Flow cytometric confirmation of CTLA-4, CD103, and KLRG1 overexpression in CD4+FoxP3+ Treg cells from spleens of Foxp3fgfp heterozygote females, on
the K/BxN and NOD backgrounds. The values shown are the percent CD103 or KLRG1-positive cells within the GFP-positive or -negative fraction of Treg cells
(mean ± SD of eight mice).
(E) Overrepresentation of the IRF4 Treg cell signature: The ratio of expression in Foxp3fgfp versus Foxp3igfp of IRF4-responsive transcripts is shown (log2 scale) for
both B6 and NOD data sets. The p value is calculated with a c2 test for departure from a null hypothesis of random distribution.
Immunity
Different Treg Cell Functions in Autoimmunityhere to have little or no impact. On the other hand, the insertion
does have pleiotropic effects, given that it influences Treg cell
lineage commitment, FoxP3 expression, and the interaction
with several transcriptional cofactors. The GFP-FoxP3 chimeramight be expected to perturb experimental situations dependent
on particular facets of Teff cell responses and sensitive to
the variation in Treg cell subphenotypes, such as the NOD or
K/BxN autoimmune models analyzed here.Immunity 36, 731–741, May 25, 2012 ª2012 Elsevier Inc. 737
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Figure 7. GFP-FoxP3 Differentially Binds Transcriptional Cofactors
(A) Association of FoxP3 with FoxP1 determined by coimmunoprecipitation. Anti-FoxP3 was used for immunoprecipitating FoxP3 from nuclear lysates of
CD4+CD25 Tconv or CD4+CD25+ Treg cells from B6.Foxp3fgfp or WT mice, and immunoblots were probed for FoxP1 (anti-FoxP3 as control).
(B) Nuclear lysates of B6.Foxp3fgfp and B6.Foxp3igfp CD25+ Treg cells were immunoprecipitated with anti-FoxP3 or control IgG and probed with anti-HIF1-a
(anti-FoxP3 and anti-b-actin as controls).
(C) Anti-IRF4 was used for immunoprecipitating IRF4 from nuclear lysates CD4+CD25+ Treg cells from B6.Foxp3fgfp or WT mice and immunoblotted for FoxP3.
(D) Immunoblot analysis of IRF4 from nuclear lysates of CD4+CD25+ Treg cells from B6.Foxp3fgfp or WT mice; three independent experiments are shown.
Immunity
Different Treg Cell Functions in AutoimmunityFrom the standpoint of autoimmune diseases, the dichoto-
mous outcome is consistent with the different effector mecha-
nisms involved in NOD diabetes and K/BxN arthritis. Pathogen-
esis in the former case involves inflammatory infiltration of the
target organ directly by autoreactive Th1 cell-like T cells, and it
is independent of IL-4 (Wang et al., 1998; Katz et al., 1995;
Hung et al., 2005). Although the impact of IL-17 on NOD diabetes
has yet to be conclusively established, there are several indica-
tions that IL-17 is protective, as demonstrated in several reports
showing that mice with high amounts of IL-17 induced by
helminth infection, segmented filamentous bacteria (SFB) or
NADPH oxidase deficiency are protected from diabetes (Lau
et al., 2011; Nikoopour et al., 2010; Tse et al., 2010; Kriegel
et al., 2011). In the K/BxN model, in contrast, pathology is due
to overwhelming T cell help to B cells, in a process strongly
dependent on both IL-4 and IL-17 (Ohmura et al., 2005; Wu
et al., 2010). Treg cells in Foxp3fgfp mice are the genomic oppo-
site of IRF4-deficient Treg cells, which are primarily defective in
controlling Th2- or Th17-linked B cell responses, resulting in
a pathology dominated by uncontrolled production of autoreac-738 Immunity 36, 731–741, May 25, 2012 ª2012 Elsevier Inc.tive Ig (Zheng et al., 2009): the discrete signature whose expres-
sion was lost in the IRF4-deficient cells proved overexpressed in
Foxp3fgfp Treg cells. Correspondingly, the in vitro assay showed
an enhanced ability of Foxp3fgfp Treg cells to suppress IL-17
production, but not IL-4 (although the assay may have been
saturated). This heightened ability of Foxp3fgfp Treg cells to
suppress Th17 cell differentiation would translate as more effec-
tive suppression of anti-GPI autoantibodies and arthritis in vivo.
Onemight speculate that imbalances in the ability of Treg cells
to suppress different facets of effector cell responses may occur
naturally and are involved in the determinism of autoimmune
diseases. The consensus is that neither diabetes nor arthritis
patients have generic defects in Treg cell numbers or basic func-
tionality. However, more focused perturbations in their flavor of
suppressor activity may contribute to arthritis or diabetes
susceptibility, conferred by genetic variation or environmental
exposure.
There is an interesting parallel between the effects reported
here and those of gut-resident microbes. We have recently re-
ported that SFB enhance K/BxN arthritis but protect NOD mice
Immunity
Different Treg Cell Functions in Autoimmunityfrom diabetes (Wu et al., 2010; Kriegel et al., 2011), a mirror
image of the effect of GFP-FoxP3. In this vein, we have noticed
that the protection from arthritis conferred by Foxp3fgfp Treg cells
can be more or less marked in different animal facilities (less
dramatic in conditions where the disease is inherently more
severe). Variations in IL-17 may be the common link, but one
might speculate that SFB also acts by influencing Treg cell
subphenotypes.
Underlying these disease changes are the subtle but highly
evocative alterations detected in the transcriptome of Foxp3fgfp
Treg cells. Of particular interest is the strong overlap with the
IRF4-dependent gene set determined by Zheng et al. (2009).
This IRF4 gene signature includes several of the ‘‘usual
suspects’’ among effector molecules (CTLA4, TIGIT, ICOS, and
FGL2). It also includes transcription factors such as AHR,
BLIMP1 (encoded by Prdm1), and Maf, which control each other
aswell as some of the same targets (Apetoh et al., 2010;Marshall
et al., 2008). The IRF4-to-BLIMP1 connection has been previ-
ously noted as key elements of a genetic regulatory module in
B cell differentiation (Sciammas et al., 2011) and in Treg cells
(Cretney et al., 2011). Fittingly, we found a slight positive bias
of the BLIMP1 signature defined by Cretney et al. However,
this bias was less pronounced as that of the IRF4 signature,
and because Prdm1 transcripts are themselves elevated, the
inference is that the GFP-FoxP3 protein impacts on this regula-
tory module at the level of IRF4 or higher.
Underlying these genomic alterations, probably, are the
altered interactions of FoxP3 with its transcriptional partners,
as shown here and by Bettini et al. (2012). Modifying FoxP3 by
insertion of the 238 amino acids of GFP at the N-terminus might
be expected, by steric hindrance, to perturb physical interac-
tions occurring through N-terminal motifs of FoxP3 or in its 3D
vicinity, but not others involving distant domains or a different
face of the folded protein. The GFP insert has no effect on dimer-
ization with FoxP1, which occurs via leucine zipper domains,
some distance away from the N-terminus; correspondingly,
interaction with NF-AT via the FKHR domain (Wu et al., 2006)
is not affected. But interaction with HIF1-a (this work), Eos,
HDAC7, and TIP60 (Bettini et al., 2012) are reduced or abolished.
HIF1-a has recently been shown to directly bind FoxP3, resulting
in its proteasomal degradation, and thus affecting Treg cell
differentiation (Shi et al., 2011; Dang et al., 2011). This loss of
HIF1-a-FoxP3 interaction, plausibly due to steric hindrance
from the bulky domain of GFP, is consistent with the higher levels
of FoxP3 in FoxP3fgfp Treg cells.
How the GFP insert would enhance the interaction with IRF4 is
less immediately obvious. Some of this increased representation
may simply be due to the increased levels of IRF4 in the cell,
although this increase (20%–40% by densitometry) may not be
sufficient to account for the full increase in FoxP3-IRF4 complex.
A simple integrative interpretation is that HIF1-a and IRF4
partially compete for binding sites on FoxP3, with the inability
of GFP-FoxP3 to interact with HIF1-a facilitating IRF4 binding
(indeed, IRF4 and FoxP3 synergize to activate IRF4 transcription;
data not shown). Tripartite molecular interactions between
HIF1-a, IRF4, and FoxP3may also be involved (although interac-
tion between HIF1-a and IRF4 has not been reported, HIF1-a is
stabilized when bound to herpes-virus-derived viral IRF3, which
shares significant homology to cellular IRF4 [Shin et al., 2008]).An alternative possibility is that posttranslational modifications
of FoxP3, mapping to the N-terminus or indirectly affected by
the presence of the GFP insertion, would condition FoxP3’s
interactions with IRF4. For instance, acetylation of the N-terminal
region of FoxP3 results from balanced HAT and HDAC activities
(Samanta et al., 2008; Li et al., 2007a). These would very likely be
affected by the neighboring insertion, thus indirectly affecting
IRF4 binding.
In summary, there is a strong connection between the different
facets of these analyses, linking enhanced FoxP3-IRF4 interac-
tions to higher expression of IRF4-dependent Treg cell genes,
then to stronger suppression of Th2 and Th17 cell-linked
functions and autoimmune disease. It will be important to posi-
tion these in the broader context of a molecular map of FoxP30s
interactions, but these results already open the way to investiga-
tions of FoxP3-related genomics in human patients and avenues
for therapeutic modulation.
EXPERIMENTAL PROCEDURES
Mice and Autoimmune Evaluation
Foxp3igfp mice were provided by V. Kuchroo. The Foxp3fgfp (aka Foxp3tm2Ayr)
trait was crossed for generating K/BxN.Foxp3fgfp, NOD/LtJ.Foxp3fgfp,
C57BL/6.Foxp3fgfp, mice (>8 generations on both backgrounds), which were
bred and maintained in SPF facilities at Harvard Medical School. Arthritis
scores, ankle thickness measurements, and determination of anti-GPI titers
were as described (Monach et al., 2008). Mice on the NOD background
were monitored biweekly for urine glucose, with confirmation of diabetes by
blood glucose determination; mice were considered diabetic with two consec-
utive readings of blood glucose > 250 mg/dL. All experiments were done with
protocols approved by HarvardMedical School’s Institutional Animal Care and
Use Committee (IACUC protocol 02954 and 3024).
Treg Cell Isolation from Nonlymphoid Tissue
For intestinal lamina propria analysis, mesenteric fat tissue was removed, and
the intestine was opened longitudinally, washed in ice-cold PBS, and cut into
1 cm pieces; both were incubated in 25 ml DMEM containing 5 mM EDTA,
0.145 mg/mL DTT for 40 min at 37C at a rotation speed of 200 rpm. After
incubation, the epithelial cell layer was removed by vortexing and pass-
ing through a 100 mm cell strainer. The remaining intestinal pieces were
washed in PBS, cut into 1 mm2 pieces with scissors, and digested in 25 ml
of DMEM supplemented with 1 mg/mL Collagenase D (Roche), 0.15 mg/mL
DNase I (Sigma), and 200 ng/mL liberase TL (Roche), at 37C for 20 min with
rotation (200 rpm), then vortexed for 1 min and passed through a 100 mm
cell strainer.
For Treg cells from visceral adipose tissue, blood was flushed from the
organs by perfusion of PBS through the portal vein and the heart ventricle,
and epididymal adipose tissue was removed, cut into small pieces, and
digested for 20 min at 37C with collagenase type II (Sigma) in DMEM. Cell
suspensions were then filtered through a sieve, and the stromovascular
fraction was harvested by centrifugation.
In Vitro Suppression Assay
Sorted splenic Teff cells (CD4+GFP) were cultured, with or without added
Treg cells, for 72 hr in RPMI 1640, 10% FCS, 2 mM L-glutamine, penicillin/
streptomycin at 2.5 3 105 cells/well in round-bottom 96-well plates, supple-
mented with 1 3 105 APCs and 1.5 mg/mL anti-CD3. Cell proliferation was
measured by incorporation of H3-thymidine (1 mCi added in the last 18 hr of
culture).
In Vitro Suppression of Th Cell Differentiation
Splenic naive T cells (CD4+CD25CD44loCD62Lhi) from B6 mice were
sorted and cultured in complete culture medium at 1 3 105 cells/well in Th1
(anti-CD3/CD28 beads + 0.4 ng/mL of IL12), Th2 (anti-CD3/CD28 beads +
4 ng/mL Il4), or Th17 (anti-CD3/CD28 beads + IL6; 20 ng/mL and TGFb;Immunity 36, 731–741, May 25, 2012 ª2012 Elsevier Inc. 739
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Different Treg Cell Functions in Autoimmunity2 ng/mL) cell-skewing culture conditions in the presence or absence of
Foxp3fgfp or Foxp3igfp Treg cells at a 1:1 Teff/Treg ratio. After 66 hr in culture,
RNA was extracted from flow-sorted Teff cells (CD4+GFP) for quantitative
rtPCR (TaqMan).
In Vitro Th17 and Treg Cell Differentiation Assay
Splenic naive T cells (CD4+CD25CD62Lhi) from B6.CD45.1 or B6.Foxp3fgfp
(CD45.2) mice were purified by flow sorting and cocultured at a 1:1 ratio under
Th17 cell-skewing conditions: 1 3 106 cells re-suspended in complete
culture media and seeded into wells from 48 well plates coated with anti-
CD3 (2 mg/mL) and supplemented with soluble anti-CD28 (2 mg/mL), IL-6
(30 ng/mL) and TGFb (5 or 25 ng/mL). At 96 hr, cells were washed and cultured
at 37C for 4 hr with 50 ng/ml phorbol 12-myristate 13-acetate (Sigma), 1 mM
ionomycin (Sigma), and BDGolgiPlug (1:1000 dilution), then analyzed for IL17a
and FoxP3 expression by flow cytometry after intracellular staining.
Microarray Analysis
Duplicate samples of Tconv (CD3+CD4+GFP) and Treg (CD3+CD4+GFP+)
splenocytes were double-sorted to achieve > 99.0% purity, from 6 weeks
old male Foxp3fgfp and Foxp3igfp mice (B6 and NOD backgrounds). Cells
were collected directly into Trizol. RNA was labeled and hybridized to
Affymetrix Mouse Genome M1.0 ST microarrays. Raw data were back-
ground-corrected and normalized with the RMA algorithm in the GenePattern
software package (Heng and Painter, 2008). The cell populations analyzed
were generated in duplicate. Data were analyzed with the ‘‘Multiplot’’ or ‘‘Heat-
map’’ GenePattern modules.
Immunoprecipitation and Immunoblotting
Pooled spleen and LN lymphocytes of Foxp3fgfp, Foxp3igfp, or Foxp3wtB6mice
were magnetically purified with anti-CD25 antibodies and lysed on ice with
hypotonic solution (10 mm HEPES, 1.5 mM MgCl2, 10 mM KCl, and 0.05%
NP-40 like/IgePal Ca-630) supplemented with EDTA-free complete protease
inhibitors (Roche). Nuclear pellets were subsequently treated with nuclear lysis
buffer (20 mM HEPES, 300 mM NaCl, 20 mM KCl, EDTA-free complete
protease inhibitor cocktail) and MNase (Nuclease S7; Roche). Chromatin
digestion was stopped by adding EDTA to 5 mM, and post-nuclear superna-
tants were incubated with Protein-G Sepharose beads coupled to anti-
FoxP3 antibodies (FJK16, eBioscience; 10 mg/reaction) for 2 hr at 4C with
constant rotation. Bound proteins were eluted by boiling, separated by SDS-
PAGE, and electro-transferred to PVDF. After blocking (2 hr in 5% milk/13
PBS 0.02% Tween20), blots were probed overnight with anti-FoxP3 (FJK16,
eBioscience), anti-HIF1a (Hif1alpha67, Novus Biologicals), and anti-FoxP1
(Cell Signaling). FoxP3-IRF4 cointeractions used the Nuclear complex co-IP
kit (Active Motif). Nuclear extract was immunoprecipitated with 2 mg goat
anti-IRF4 (Santa Cruz), captured on magnetic protein G beads, and Foxp3
was detected after SDS-PAGE and immunoblotting.
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